| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |